Dr. Daniel Spratt on Artera’s Post‑RP test: “[It] uses clinical and pathologic features + digital pathology, running AI to help ID patients at low vs high risk of recurrence and metastasis.” Thanks @UroTimes + Hannah Clarke for the feature. heyor.ca/mI71pa #ArteraAI

AI biomarkers should work across the diverse populations they're intended to serve. New data presented at #ASTRO2026 found similar performance of the ArteraAI prostate biomarker across racial and age subgroups studied, with no evidence of bias. Read more: buff.ly/KbGFjsM

We’re heading to the @AmerUrological Western Section Annual Meeting! The Artera team looks forward to connecting with the urology community and discussing the role of AI-powered biomarkers in #ProstateCancer care. Attending? Come say hello! 👋 #ArteraOnTheGo

Two more opportunities to connect with the Artera team this October! We'll be attending the Dr. John Mordente Memorial Lecture at @nyulangone and the @gaurology Physicians Summit. Reach out to set up a meeting. #ArteraOnTheGo

This #BreastCancerAwarenessMonth, we’re highlighting research exploring how multimodal AI can provide insights into risk and treatment benefit in early-stage breast cancer. ▪️ ASCO 2026: buff.ly/E3nQcvw ▪️ SABCS 2025: buff.ly/Rpcez3X

More opportunities to connect with the Artera team this October! Find us at the @AmerUrological New England Section Meeting, @UPMC Radiation Oncology Meeting, and the NCUA Annual Meeting. #ArteraOnTheGo

How can AI help personalize #cancer treatment? Artera CEO Andre Esteva shares his perspective on treatment selection, clinical validation, expanding access and what it takes to translate AI innovation into real-world cancer care. Read more: buff.ly/8Y42PLn

We’re heading to #PathVisions26! Join the Artera team for conversations on integrated diagnostics, digital pathology and AI reimbursement, plus new data validating a multimodal AI biomarker in localized #ProstateCancer. See where to find us 👇

More opportunities to connect with the Artera team this October! Find us at the Urological Surgeons of Northern California Meeting and the 100th Annual Meeting of the @AmerUrological North Central Section. #ArteraOnTheGo

This #BreastCancerAwarenessMonth, we’re highlighting progress toward more personalized care. As our understanding of breast cancer grows, AI and precision medicine can provide deeper insights to help match the right treatment to the right patient at the right time.

From localized to metastatic #ProstateCancer, where can AI-based biomarkers help inform care? This @Medscape feature explores the growing clinical evidence behind #ArteraAI across the prostate cancer care continuum and beyond. Read more: buff.ly/QZPlToC

That’s a wrap on #ASTRO26! Thank you to everyone who connected with the Artera team throughout the meeting. We enjoyed the conversations and the opportunity to spend time with the radiation oncology community. Until next year! #ProstateCancer #RadiationOncology #ArteraOnTheGo

Find us Oct. 8–9 at the @specialtynet Fall National Conference in Tampa and @MSKCancerCenter Advances in Prostate Cancer Management event in New York. Reach out to set up a meeting! #ProstateCancer #Urology #ArteraOnTheGo

Arterans got moving for #ProstateCancerAwarenessMonth! For our second annual Virtual Walk, the team walked and ran to raise awareness and support @ZEROCancer, with Artera donating $5 for every mile completed. Thanks to everyone who joined us!

We’re kicking things off this Oct. 1–3 at the @GRUrology Innovations in Urologic Practice and the @mecmededucation Advances in Oncology Conference. See where else you can find us throughout October. 👇 #ProstateCancer #Urology #Oncology #ArteraOnTheGo

In case you missed it: research showing that multimodal AI predicts abiraterone benefit in very high-risk #ProstateCancer is heading to print in the October issue of Annals of Oncology. Read the full publication: buff.ly/zkVMcnp #ArteraAI

At #ASCO26, Xinglei Shen, MD, discussed new research evaluating Artera’s multimodal AI biomarker in a real-world population, along with findings from a new image-only model for localized #ProstateCancer. Watch the conversation: buff.ly/aKYVlmp

Artera’s Julia Ross is joining industry and regulatory leaders at the @OGPREMED CDx & #PrecisionMedicine Conference for a discussion on the evolving regulatory landscape for AI-derived biomarkers. Attending? Add the session to your agenda: buff.ly/PL57hJ5

Not all men experience #ProstateCancer equally. African American men face greater risk and mortality, yet remain underrepresented in clinical research. This #ProstateCancerAwarenessMonth, we’re highlighting why representation matters. #MindTheGap

Heading to #ASTRO26? The Artera team will be onsite and looking forward to connecting with the radiation oncology community and discussing the role of AI-powered biomarkers in #ProstateCancer care. #ArteraOnTheGo

In our latest blog, Brad Macdonald goes behind the scenes of the data infrastructure Artera built to prepare thousands of gigapixel-scale pathology images for model development. Read more: buff.ly/beVrNpP #ArteraAI